Fairmount Funds Management LLC - Insider Trading & Ownership

Entity
Company
Location
200 Barr Harbor Drive, Suite 400, West Conshohocken, Pennsylvania
Summary
The estimated value of insider holdings of Fairmount Funds Management LLC is at least $283 M dollars as of June 12, 2024. Fairmount Funds Management LLC is the Director of Apogee Therapeutics, Inc. and owns shares of Apogee Therapeutics, Inc. (APGE) stock worth about $151 M. Fairmount Funds Management LLC is the Director of Cogent Biosciences, Inc. and owns shares of Cogent Biosciences, Inc. (COGT) stock worth about $46.7 M. Fairmount Funds Management LLC is the Director of Dianthus Therapeutics, Inc. /DE/ and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $43.1 M. Fairmount Funds Management LLC is the Director, 10%+ Owner of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $38.8 M. Fairmount Funds Management LLC is the Director of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (AGLE) stock worth about $2.71 M.
All Insider Reports
All Insider Reports

Ownership of Fairmount Funds Management LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APGE Apogee Therapeutics, Inc. Director $151 M +$50 M +49.4% Jun 5, 2024
COGT Cogent Biosciences, Inc. Director $46.7 M Jun 10, 2024
DNTH Dianthus Therapeutics, Inc. /DE/ Director $43.1 M +$1.4 M +3.35% May 23, 2024
VRDN Viridian Therapeutics, Inc.\DE Director, 10%+ Owner $38.8 M +$10 M +34.8% Mar 28, 2024
AGLE Spyre Therapeutics, Inc. Director $2.71 M May 14, 2024

Insider Transactions Reported by Fairmount Funds Management LLC:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership